Clinical Trial Update: Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pramipexole versus escitalopram for major depressive disorder with comorbid mild neurocognitive disorder in people with HIV; currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Major Depressive Disorder
• Neurocognitive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Pramipexole (pramipexole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Major Depressive Disorder, Mild Neurocognitive Disorder | Phase 2 | Status: RECRUITING